Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy

E-ISSN： 1875-5992|14|2|211-222

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.14, Iss.2, 2014-02, pp. : 211-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adoptive Transfer of Ex Vivo Activated Memory T-cells With or Without Cyclophosphamide for Advanced Metastatic Melanoma: Results in 36 Patients

By Gold J.E. Ross S.D. Krellenstein D.J. LaRosa F. Malamud S.C. Osband M.E.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 698-708

Elsevier

Access to resources Recommend Favorite

Recent Advances in T Cell Adoptive Immunotherapy of Cancer

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer

By Karlsson Mona Marits Per Dahl Kjell Dagöö Tobias Enerbäck Sven Thörn Magnus Winqvist Ola

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1747-1757

Springer Publishing Company

Access to resources Recommend Favorite

Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

By Zhang Tianqian

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 475-492

Springer Publishing Company

Access to resources Recommend Favorite

Cancer Immunotherapy Trials Underutilize Immune Response Monitoring

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 116-117

John Wiley & Sons Inc

Access to resources Recommend Favorite